✦ LIBER ✦

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

✍ Scribed by Ohtsu, A.; Shah, M. A.; Van Cutsem, E.; Rha, S. Y.; Sawaki, A.; Park, S. R.; Lim, H. Y.; Yamada, Y.; Wu, J.; Langer, B.; Starnawski, M.; Kang, Y.-K.

Book ID: 125531662
Publisher: American Society of Clinical Oncology
Year: 2011
Tongue: English
Weight: 203 KB
Volume: 29
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2011.36.2236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in Combination With Oxalipla

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

✍ Saltz, L. B.; Clarke, S.; Diaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 157 KB

A double-blind, randomised, placebo-cont

A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer

✍ Gradishar, William J.; Kaklamani, Virginia; Sahoo, Tarini P.; Lokanatha, Dasappa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 820 KB

Cediranib With mFOLFOX6 Versus Bevacizum

Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)

✍ Schmoll, H.-J.; Cunningham, D.; Sobrero, A.; Karapetis, C. S.; Rougier, P.; Kosk 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer

✍ Robert A. Wolff; Martin Fuchs; Maria Di Bartolomeo; Anwar M. Hossain; Clemens St 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

A double-blind, placebo-controlled, rand

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

✍ Jaime Coronel; Lucely Cetina; Irlanda Pacheco; Catalina Trejo-Becerril; Aurora G 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 210 KB

Randomized, Phase II, Placebo-Controlled

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer

✍ Vergote, Ignace B. (author);Amant, Frederic (author);Chekerov, Radoslav (author) 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB